2017-12-14 |
100 |
|
the '772 patent, and U.S. Patent No. 6,004,973 ("the '973
patent") are prior…x27;973 Patent
U.S. Patent No. 6,004,973 issued on December 21, 1999. The '973 patent discloses…3 of U.S. Patent No. 8,410,131 ("the '131 patent") and claim 1 of U.S. Patent
No. 9,006,224…x27;772 Patent
U.S. Patent No. 5,665,772 issued on September 9, 1997. The '772 patent discloses…itself is claimed in U.S. Patent No.
5,665,772 ("the '772 patent"), which is not at issue |
External link to document |
2018-01-02 |
104 |
|
Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,006,224; 8,410,131. (Attachments…
21 December 2017
1:15-cv-00474
830 Patent
None
District Court, D. Delaware
|
External link to document |
2020-01-28 |
114 |
Redacted Document |
the ’772 patent”)
and 7,297,703 (“the ’703 patent”). See id. at ¶¶ 21–23. These three patents gave Par… 9/9/2019 3/9/2020
7,297,703 12/6/2019 6/6/2020
…. 18, 2014). The patents
included in the Paragraph IV Certification were U.S. Patent Nos. 5,665,772 (…complaint for patent infringement was filed, Novartis filed additional
complaints for patent infringement…proceeded with discovery regarding the remaining patents, U.S. Patent Nos.
8,410,131 and 9,006,224. This Court |
External link to document |
2016-01-18 |
25 |
|
Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,410,131 and 9,006,224 filed by Roxane Laboratories…
21 December 2017
1:15-cv-00474
830 Patent
None
District Court, D. Delaware
|
External link to document |